Document is current
Any future updates will be listed below
-
Authors
Saw, Eng Leng
Pearson, James T. https://orcid.org/0000-0002-3318-5406
Schwenke, Daryl O.
Munasinghe, Pujika Emani
Tsuchimochi, Hirotsugu
Rawal, Shruti
Coffey, Sean
Davis, Philip
Bunton, Richard
Van Hout, Isabelle
Kai, Yuko
Williams, Michael J. A.
Kakinuma, Yoshihiko
Fronius, Martin https://orcid.org/0000-0002-3553-7786
Katare, Rajesh https://orcid.org/0000-0001-5419-7935
-
Funding
Funding for this research was provided by:
Lottery Health Research (R-LHR-2020-128280)
- License Information
-
More Information
Article History
Received: 12 November 2020
Accepted: 29 January 2021
First Online: 22 February 2021
Ethics approval and consent to participate
: The Animal Ethics Committee from the University of Otago (AEC25/12), Nippon Medical School (27-003) and the Animal Experiment Committee of SPring-8 (2018A1282), which conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes approved the use of animals in this study. The Health and Disability Ethics Committee in New Zealand approved the use of human left ventricular (LV) tissues (LRS/12/01/001/AM13). The human LV tissues of patients with or without type-2 diabetes with coronary artery disease (CAD) who underwent coronary artery bypass grafting (CABG) surgery in Dunedin hospital were collected following written informed consent. The investigation with human tissue conformed to the principles outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
